Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Operating Activities
Net Income $-24.5M $-1.3M $4.5M $3.3M $-25.5K
Depreciation & Amortization — — — — —
Depreciation — — — — —
Amortization — — — — —
Stock-Based Compensation $14.1M — — — —
Net Cash from Operating Activities $-4.9M $-265.2K $-653.1K $-1.4M $-238.6K
Investing Activities
Capital Expenditures — — — — —
Business Acquisitions — — — — —
Net Cash from Investing Activities — $13.8M $284.9M $-294.7M —
Financing Activities
Dividends Paid — — — — —
Stock Repurchases — $13.8M $284.9M — —
Net Cash from Financing Activities $5.9M $257.6K $-284.8M $296.6M $238.6K
Net Change in Cash $1.0M $-7.5K $-497.3K $497.3K —
Free Cash Flow — — — — —